Proposal:Accelerated Approval Transparency Act

This proposal is archived and closed to further debate. It was introduced in the 117th Congress, which has concluded, and the bill was not enacted into law.

Bill	S 4390
Type of Legislation	Senate Bill
Congress	117
Status	Archived — 117th Congress concluded
Source	View original on Congress.gov

Geographic Scope

National

Description

Accelerated Approval Transparency Act

This bill requires the Food and Drug Administration to include a summary of the reasons a drug or biologic received accelerated approval to treat a serious or life-threatening disease or condition in the public action package for the drug or biologic.

Bill Title

Accelerated Approval Transparency Act

Linked Goals

• Goal:Promote General Welfare

Steps

• 2022-06-14: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
• 2022-06-14: Introduced in Senate

Projected Outcome

A more informed proposal or public response aligned with the Promote General Welfare goal.